Progressive TP53 inactivation in an aggressive splenic diffuse red pulp small B-cell lymphoma

Leuk Lymphoma. 2024 Jul;65(7):1003-1007. doi: 10.1080/10428194.2024.2332508. Epub 2024 Mar 22.

Authors

Maria-Myrsini Tzioni¹, Alexandra Clipson¹, Zi Chen¹, Francesco Cucco¹, Andrew Wotherspoon², Stefan Dojcinov³, Ming-Qing Du¹

Affiliations

¹ Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
² Histopathology Department, The Royal Marsden Hospital, London, UK.
³ Department of Pathology, Morriston Hospital, Swansea Bay University Health Board/Swansea University, Swansea, UK.

PMID: 38516899
DOI: 10.1080/10428194.2024.2332508

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Female
Humans
Lymphoma, B-Cell / diagnosis
Lymphoma, B-Cell / genetics
Lymphoma, B-Cell / pathology
Male
Middle Aged
Splenic Neoplasms* / diagnosis
Splenic Neoplasms* / genetics
Splenic Neoplasms* / pathology
Tumor Suppressor Protein p53* / genetics

Substances

Tumor Suppressor Protein p53
TP53 protein, human